(NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor TUKYSA ® (tucatinib) in patients with ...

Formula 1 is no longer just a racing series. It is a global entertainment product built on a foundation of speed, spectacle, ...